Format

Send to

Choose Destination
Br J Pharmacol. 2008 Apr;153(8):1587-8. doi: 10.1038/bjp.2008.74. Epub 2008 Mar 17.

Lipoic acid supplementation and endothelial function.

Author information

1
Department of Medicine, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada. jean.claude.tardif@icm-mhi.org

Abstract

Endothelial dysfunction is caused by all the recognized cardiovascular risk factors and has been implicated in the complex processes leading to the initiation and progression of atherosclerosis. Short-term treatment with lipoic acid is shown in the current issue of the British Journal of Pharmacology to improve endothelial function of aortic rings of old rats. The age-related decrease in phosphorylation of nitric oxide synthase and Akt was improved by lipoic acid supplementation. The improved phosphorylation status may have been due to reduced activity of the phosphatase PPA2, associated with decreased levels of endothelial ceramide induced by lipoic acid. Neutral sphingomyelinase activity was also reduced by lipoic acid, which was due, at least in part, to increased glutathione levels in endothelial cells. The favourable antioxidant, anti-inflammatory, metabolic and endothelial effects of lipoic acid shown in rodents, in this and other recently published studies, warrant further assessment of its potential role for prevention and treatment of cardiovascular diseases.

PMID:
18345023
PMCID:
PMC2438258
DOI:
10.1038/bjp.2008.74
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center